Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.
This article is from
The Cancer Letter
archive.
Vol. 27 No. 17 | April 27, 2001
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
NCI Statisticians Disputes Bross Claim
April 27, 1979
TCL Archive
Relative Survival Now May be Over 50%, DeVita Says
December 3, 1982
TCL Archive
FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension
June 20, 2003
TCL Archive
Community Assn. Plan Meeting In DC On Program Problems
November 29, 1974
TCL Archive
Panel Suggests Test Of Paid Advertising For ACS: Roundup
August 7, 1992
TCL Archive
AGS-003 Increased Survival In Combination with Sunitinib
February 24, 2012